Author: Lynne Taylor

Legislation introduced in the US House and Senate would close a current legal loophole which exempts generic drugmakers from paying a rebate to Medicaid if their products’ prices increase faster than inflation.

The current “target culture” within the NHS is leading to patients getting the wrong treatment, a major new report has warned.

Australia and New Zealand have abandoned plans to create a joint medicines regulatory agency, after a review found it would not create adequate cost benefits for either nation.

Global spending on medicines is set to soar by as much as 30% from 2013 to 2018, and by the latter year total expenditures will be nearly $1.3 trillion, according to new forecasts.

People with diabetes are being denied the opportunity to effectively monitor their blood glucose levels because their prescriptions for test strips are being restricted, the charity Diabetes UK has reported.